Another study used nanoparticles to treat colon carcinoma, combining a BRAF inhibitor with miR‐200c, which can downregulate PD‐L1 expression and participate in the enhancement of the anti‐tumour immune response.59 This evidence concerns the gene BRAF and neoplasm.